Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
INTARCIA THERAPEUTICS, INC See All Filings	D/A	2020-01-14 17:29:46 UTC
Amount To Be Raised $280,000,000 Associated Brokers / Dealers Morgan Stanley & Co. LLC CIK Number 0001086688 Filed Document 0001086688-20-000001 Exclusions or Exemptions 506b Accepted Date 2020-01-14 17:29:46 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Debt
INTARCIA THERAPEUTICS, INC See All Filings	D	2019-03-12 12:53:50 UTC
Amount To Be Raised $150,000,000 Associated Brokers / Dealers Morgan Stanley & Co. LLC CIK Number 0001086688 Filed Document 0001086688-19-000001 Exclusions or Exemptions 506b Accepted Date 2019-03-12 12:53:50 UTC Type of Offering D Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Debt
INTARCIA THERAPEUTICS, INC See All Filings	D/A	2017-08-03 18:28:12 UTC
Amount To Be Raised $850,000,020 Associated Brokers / Dealers Morgan Stanley & Co. LLC, N/A, N/A, UBS Securities LLC, and Raptor International, LLC CIK Number 0001086688 Filed Document 0001086688-17-000004 Exclusions or Exemptions 506b Accepted Date 2017-08-03 18:28:12 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
INTARCIA THERAPEUTICS, INC See All Filings	D/A	2017-04-03 11:34:31 UTC
Amount To Be Raised $650,000,040 Associated Brokers / Dealers Morgan Stanley & Co. LLC, N/A, and UBS Securities LLC CIK Number 0001086688 Filed Document 0001086688-17-000003 Exclusions or Exemptions 506b Accepted Date 2017-04-03 11:34:31 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
INTARCIA THERAPEUTICS, INC See All Filings	D	2017-01-13 09:17:11 UTC
Amount To Be Raised $3,594 Associated Brokers / Dealers N/A CIK Number 0001086688 Filed Document 0001086688-17-000002 Exclusions or Exemptions 506b Accepted Date 2017-01-13 09:17:11 UTC Type of Offering D Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
INTARCIA THERAPEUTICS, INC See All Filings	D/A	2017-01-06 16:34:34 UTC
Amount To Be Raised $650,000,040 Associated Brokers / Dealers Morgan Stanley & Co. LLC and N/A CIK Number 0001086688 Filed Document 0001086688-17-000001 Exclusions or Exemptions 506b Accepted Date 2017-01-06 16:34:34 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
INTARCIA THERAPEUTICS, INC See All Filings	D	2016-09-15 15:53:06 UTC
Amount To Be Raised $600,000,000 Associated Brokers / Dealers Morgan Stanley & Co. LLC CIK Number 0001086688 Filed Document 0001086688-16-000002 Exclusions or Exemptions 506b Accepted Date 2016-09-15 15:53:06 UTC Type of Offering D Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
INTARCIA THERAPEUTICS, INC See All Filings	D	2014-04-03 00:00:00 UTC
Amount To Be Raised $200,000,023 Associated Brokers / Dealers N/A CIK Number 0001086688 Filed Document 0001086688-14-000002 Exclusions or Exemptions 506b Accepted Date 2014-04-03 00:00:00 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity